Total Payments
$866,963
2024 Payments
$41,989
Companies
42
Transactions
1,478
Medicare Patients
2,510
Medicare Billing
$415,051
Payment Breakdown by Category
Other$615,013 (70.9%)
Consulting$124,007 (14.3%)
Travel$83,840 (9.7%)
Food & Beverage$37,383 (4.3%)
Research$5,604 (0.6%)
Education$1,116 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $610,738 | 257 | 70.4% |
| Consulting Fee | $124,007 | 40 | 14.3% |
| Travel and Lodging | $83,840 | 223 | 9.7% |
| Food and Beverage | $37,383 | 917 | 4.3% |
| Unspecified | $5,604 | 5 | 0.6% |
| Honoraria | $4,275 | 3 | 0.5% |
| Education | $1,116 | 33 | 0.1% |
Payments by Type
General
$861,358
1,473 transactions
Research
$5,604
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $236,360 | 309 | $0 (2024) |
| Genentech USA, Inc. | $210,651 | 241 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $123,960 | 188 | $0 (2024) |
| GENZYME CORPORATION | $62,446 | 111 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $41,267 | 57 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $32,532 | 18 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $31,314 | 103 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $26,782 | 32 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17,800 | 56 | $0 (2022) |
| Optinose US, Inc. | $14,699 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,989 | 76 | Regeneron Healthcare Solutions, Inc. ($12,876) |
| 2023 | $88,753 | 178 | Regeneron Healthcare Solutions, Inc. ($41,278) |
| 2022 | $92,916 | 180 | Regeneron Healthcare Solutions, Inc. ($31,982) |
| 2021 | $89,684 | 158 | GlaxoSmithKline, LLC. ($44,381) |
| 2020 | $43,630 | 114 | GlaxoSmithKline, LLC. ($23,998) |
| 2019 | $259,166 | 299 | GlaxoSmithKline, LLC. ($89,614) |
| 2018 | $144,301 | 244 | Genentech USA, Inc. ($67,371) |
| 2017 | $106,522 | 229 | Genentech USA, Inc. ($30,678) |
All Payment Transactions
1,478 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.24 | General |
| 11/07/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $500.00 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $83.77 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,647.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,226.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,583.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,482.00 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $749.37 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | — | In-kind items and services | $273.74 | Research |
| Study: Clinical Burden and Unmet Need for Severe Asthma and New Users of Biologics • Category: Inflammation | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH COSENTYX RESEARCH | Novartis Pharmaceuticals Corporation | $2,250 | 1 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,885 | 1 |
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $1,000 | 1 |
| Clinical Burden and Unmet Need for Severe Asthma and New Users of Biologics | Amgen Inc. | $273.74 | 1 |
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $195.60 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 691 | 6,752 | $269,341 | $116,911 |
| 2022 | 14 | 656 | 6,235 | $258,293 | $115,578 |
| 2021 | 16 | 626 | 5,794 | $236,351 | $102,960 |
| 2020 | 14 | 537 | 4,610 | $187,223 | $79,602 |
Total Patients
2,510
Total Services
23,391
Medicare Billing
$415,051
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 520 | $63,540 | $41,193 | 64.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 67 | 2,411 | $56,403 | $33,060 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $24,300 | $12,177 | 50.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 76 | 2,280 | $36,540 | $9,510 | 26.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 57 | 675 | $34,320 | $7,283 | 21.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 94 | 266 | $31,920 | $6,055 | 19.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 373 | $13,055 | $4,347 | 33.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 27 | 38 | $5,025 | $1,417 | 28.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $880.00 | $791.56 | 90.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 24 | 24 | $1,200 | $491.04 | 40.9% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 18 | 19 | $760.00 | $337.68 | 44.4% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 20 | 27 | $1,350 | $248.13 | 18.4% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 14 | 16 | $48.00 | $0.41 | 0.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 71 | 2,569 | $60,655 | $37,534 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 455 | $56,010 | $36,135 | 64.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $24,000 | $11,252 | 46.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 62 | 670 | $34,280 | $7,276 | 21.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 55 | 1,630 | $27,440 | $6,976 | 25.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 80 | 239 | $28,680 | $5,699 | 19.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 308 | $10,780 | $4,168 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 20 | $3,500 | $2,461 | 70.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 16 | 149 | $5,780 | $1,302 | 22.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,160 | $1,024 | 88.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 21 | 27 | $3,575 | $970.59 | 27.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 29 | 29 | $1,450 | $581.87 | 40.1% |
About Dr. Stanley Goldstein, MD
Dr. Stanley Goldstein, MD is a Allergy & Immunology healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548343304.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanley Goldstein, MD has received a total of $866,963 in payments from pharmaceutical and medical device companies, with $41,989 received in 2024. These payments were reported across 1,478 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($610,738).
As a Medicare-enrolled provider, Goldstein has provided services to 2,510 Medicare beneficiaries, totaling 23,391 services with total Medicare billing of $415,051. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Rockville Centre, NY
- Active Since 10/23/2006
- Last Updated 09/06/2011
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1548343304
Products in Payments
- NUCALA (Biological) $207,152
- Xolair (Biological) $191,650
- DUPIXENT (Biological) $168,004
- TEZSPIRE (Biological) $32,786
- XOLAIR (Biological) $31,628
- SPIRIVA (Drug) $31,324
- TRELEGY ELLIPTA (Drug) $21,810
- DUPIXENT DUPILUMAB INJECTION (Biological) $20,977
- DUPIXENT (Drug) $18,178
- Xhance (Drug) $14,699
- CINQAIR (Drug) $13,670
- Odactra (Drug) $11,873
- SPIRIVA RESPIMAT (Drug) $10,198
- FASENRA (Drug) $9,579
- UTIBRON (Drug) $9,083
- Dymista (Drug) $7,505
- COSENTYX (Biological) $3,558
- LONHALA MAGNAIR (Drug) $2,768
- QVAR (Drug) $2,387
- RESLIZUMAB (Drug) $834.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.